BioWorld

Oct. 29, 2007

View Archived Issues

While RA Bids Line Runway, Poll Finds Unhappy Patients

The phrase "rheumatoid arthritis" almost right away calls to mind Genentech Inc.'s Rituxan (rituximab, which targets the CD20 antigen, for RA and non-Hodgkin's lymphoma). (BioWorld Financial Watch) Read More

Money Raised By Month

Read More

Stock Winners and Losers For The Week

Read More

Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: Aug. 31 - Oct. 18, 2007

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More